BioCurate
Overview
BioCurate is an Australian venture catalyst and investment firm that bridges the gap between academic biomedical research and industry by providing expertise, project management, and financial resources to translate early-stage discoveries into therapeutic candidates.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| xCystence Bio | Mar 2026 | Pre Seed | Co-investor |
Key People
Kathy Nielsen
Chief Executive Officer
Ken Jefferd
Non Executive Director
Frederico Calhabeu
Director of Cell and Gene Therapies
Jaclyn Sceneay
Director Translational Biology
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioCurate based?
BioCurate is headquartered in Melbourne, Australia.
When was BioCurate founded?
BioCurate was founded in 2016.
How many portfolio companies does BioCurate have?
BioCurate has 1 portfolio company in Caplight's dataset.
What are some companies in BioCurate's portfolio?
Portfolio companies visible on Caplight include xCystence Bio.
What was BioCurate's most recent investment shown here?
BioCurate's most recent investment in this portfolio sample was in xCystence Bio in 2026.
What sectors does BioCurate focus on?
BioCurate focuses on Healthcare & Life Sciences.
What company stages does BioCurate focus on?
BioCurate typically invests at the Early stage.
What is BioCurate's AUM?
BioCurate's assets under management are estimated between $52.8M and $52.8M.